References:
- Berenholz L, Katzenell U, Harell M. Evolving resistant pseudomonas to
ciprofloxacin in malignant otitis externa. Laryngoscope .
2002;112(9):1619‐1622. doi:10.1097/00005537-200209000-00017
- Mani N, Sudhoff H, Rajagopal S, Moffat D, Axon PR. Cranial nerve
involvement in malignant external otitis: implications for clinical
outcome. Laryngoscope . 2007;117(5):907‐910.
doi:10.1097/MLG.0b013e318039b30f
- Peled C, El-Seid S, Bahat-Dinur A, et al. Necrotizing Otitis
Externa-Analysis of 83 Cases: Clinical Findings and Course of
Disease. OtolNeurotol . 2019;40(1):56‐62.
doi:10.1097/MAO.0000000000001986
- Mahdyoun P, Pulcini C, Gahide I, et al. Necrotizing otitis externa: a
systematic review. OtolNeurotol . 2013;34(4):620‐629.
doi:10.1097/MAO.0b013e3182804aee
- Hollis S, Evans K. Management of malignant (necrotising) otitis
externa. J Laryngol Otol . 2011;125(12):1212‐1217.
doi:10.1017/S0022215110002550
- Joshua BZ, Sulkes J, Raveh E, Bishara J, Nageris BI. Predicting
outcome of malignant external otitis. OtolNeurotol .
2008;29(3):339‐343. doi:10.1097/MAO.0b013e3181661879
- Loh S, Loh WS. Malignant otitis externa: an Asian perspective on
treatment outcomes and prognostic factors. Otolaryngol Head Neck
Surg . 2013;148(6):991‐996. doi:10.1177/0194599813482107
- Franco-Vidal V, Blanchet H, Bebear C, Dutronc H, Darrouzet V.
Necrotizing external otitis: a report of 46
cases. OtolNeurotol . 2007;28(6):771‐773.
doi:10.1097/MAO.0b013e31805153bd
- Cohen D, Friedman P. The diagnostic criteria of malignant external
otitis. J Laryngol Otol . 1987;101(3):216‐221.
doi:10.1017/s0022215100101562
- American Diabetes Association. Diabetes Care in the
Hospital: Standards of Medical Care in
Diabetes-2019 . Diabetes Care . 2019;42(Suppl 1):S173‐S181.
doi:10.2337/dc19-S015
- Peled C, Kraus M, Kaplan D. Diagnosis and treatment of necrotising
otitis externa and diabetic foot osteomyelitis - similarities and
differences. J Laryngol Otol . 2018;132(9):775‐779.
doi:10.1017/S002221511800138X
- Stern Shavit S, Soudry E, Hamzany Y, Nageris B. Malignant external
otitis: Factors predicting patient outcomes. Am J Otolaryngol .
2016;37(5):425‐430. doi:10.1016/j.amjoto.2016.04.005
- Lee SK, Lee SA, Seon SW, et al. Analysis of Prognostic Factors in
Malignant External Otitis. ClinExpOtorhinolaryngol .
2017;10(3):228‐235. doi:10.21053/ceo.2016.00612
- Carfrae MJ, Kesser BW. Malignant otitis externa. OtolaryngolClin
North Am . 2008;41(3):537‐ix. doi:10.1016/j.otc.2008.01.004
- Chen CN, Chen YS, Yeh TH, Hsu CJ, Tseng FY. Outcomes of malignant
external otitis: survival vs mortality. ActaOtolaryngol .
2010;130(1):89‐94. doi:10.3109/00016480902971247
- Naghibi M, Smith RP, Baltch AL, et al. The effect of diabetes mellitus
on chemotactic and bactericidal activity of human polymorphonuclear
leukocytes. Diabetes Res ClinPract . 1987;4(1):27‐35.
doi:10.1016/s0168-8227(87)80030-x
- Geerlings SE, Hoepelman AI. Immune dysfunction in patients with
diabetes mellitus (DM). FEMS Immunol Med Microbiol .
1999;26(3-4):259‐265. doi:10.1111/j.1574-695X.1999.tb01397.x